SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10705	Companies
229086	Keywords
157714	Articles
121645	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 12/09/2024 at 20:11, 1 year 7 months ago

Sarclisa Combinations Show Promise in Multiple Myeloma Treatment

Clinical Study Multiple Myeloma Sarclisa MRD Negativity Treatment Efficacy
PRESS RELEASE

published on 12/09/2024 at 20:06, 1 year 7 months ago

Press Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients
New data presented at ASH demonstrates significant clinical benefit with Sarclisa-based combinations in newly diagnosed multiple myeloma patients, highlighting deep and durable responses and improved outcomes

Multiple Myeloma Sarclisa ASH MRD Negativity Clinical Benefit
BRIEF

published on 12/07/2024 at 17:35, 1 year 7 months ago

Rilzabrutinib: Promising Advances in the Treatment of IPT

Security Efficiency Phase III Rilzabrutinib TPI
PRESS RELEASE

published on 12/07/2024 at 17:30, 1 year 7 months ago

Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
Positive phase 3 study shows rilzabrutinib benefits in ITP patients. Results include platelet response, reduced bleeding, improved quality of life. Safety and efficacy highlighted

Phase 3 Study Rilzabrutinib ITP BTK Inhibitor Patient Benefit
BRIEF

published on 12/06/2024 at 07:35, 1 year 7 months ago

Sanofi Publishes Revised Financial Statements Excluding Opella

Financial Statements Biopharma Sanofi 2024 Results Opella
PRESS RELEASE

published on 12/06/2024 at 07:30, 1 year 7 months ago

Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Sanofi releases revised financial statements excluding Opella. The adjustments classify Opella as discontinued operations, aligning with Sanofi's transition to a biopharma company. Q4 2024 results expected on Jan 30, 2025

Sanofi Discontinued Operations Opella Revised Financial Statements Biopharma Company
PRESS RELEASE

published on 10/25/2024 at 07:30, 1 year 8 months ago

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
BRIEF

published on 10/24/2024 at 14:05, 1 year 8 months ago

Positive Phase 3 Data for Dupixent in Chronic Spontaneous Urticaria Released

Dupixent Chronic Spontaneous Urticaria Phase 3 Data ACAAI Presentation Treatment Innovation
PRESS RELEASE

published on 10/24/2024 at 14:00, 1 year 8 months ago

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
Dupixent phase 3 data in chronic spontaneous urticaria presented at ACAAI shows reduced itch and hive activity, potential new treatment for CSU patients

Dupixent Chronic Spontaneous Urticaria ACAAI Phase 3 Data Targeted Treatment
BRIEF

published on 10/21/2024 at 07:35, 1 year 8 months ago

Sanofi and CD&R join forces to grow Opella

Financial Transaction Sanofi CD&R Opella Consumer Health

Accesswire

Published on 07/10/2026 at 14:20, 27 minutes ago

Giyani Announces Filing of Definitive Feasibility Study
Published on 07/10/2026 at 14:00, 47 minutes ago

Orogen Royalties Begins Trading on OTCQX Best Market
Published on 07/10/2026 at 13:30, 1 hour 17 minutes ago

Empress Announces Acquisition of North American Royalty Portfolio
Published on 07/10/2026 at 13:30, 1 hour 17 minutes ago

Caldwell Appoints John Blank as Chief Operating Officer and Names Regional Managing Partners
Published on 07/10/2026 at 08:00, 6 hours 47 minutes ago

Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder

View all ACCESSWIRE

EQS Group

Published on 07/10/2026 at 14:35, 11 minutes ago

CHANGES TO THE BOARD OF DIRECTORS
Published on 07/10/2026 at 14:26, 20 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 07/10/2026 at 14:25, 21 minutes ago

Edison issues report on Patria Private Equity Trust (PPET)
Published on 07/10/2026 at 14:17, 30 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 07/10/2026 at 14:11, 35 minutes ago

HORNBACH Holding AG & Co. KGaA Annual General Meeting 2026: Dividend confirmed and first step toward staggered board completed

Les Echos

Published on 07/10/2026 at 10:34, 4 hours 12 minutes ago

Number of shares and voting rights - June 2026 (In French only)
Published on 07/09/2026 at 18:00, 20 hours 47 minutes ago

Second-quarter 2026 activity: +7% (vs. Q2 2025)
Published on 07/09/2026 at 18:00, 20 hours 47 minutes ago

Half-year report on Deezer’s liquidity contract with BNP Paribas
Published on 07/09/2026 at 17:45, 21 hours 2 minutes ago

Air Liquide to invest over 200M USD to support chemical manufacturing expansion in Texas
Published on 07/09/2026 at 15:50, 22 hours 56 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of June 30, 2026

View all LES ECHOS COMFI WIRE